Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients

doi:10.3748/wjg.v21.i19.6018

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5997)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

463

WORD

353

HTML

2934

Figures (1-2)

164

Tables (1-3)

126

Sum=4040

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

940

Download

1017

Sum=1957

May 21, 2015 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (37)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. May 21, 2015; 21(19): 6018-6025
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.6018

Table 1 Eligibility criteria for treatment with trans-arterial chemoembolization

HCC

Cytohistologically confirmed

Unresectable (technical reasons, comorbidities, refusal of treatment)

Adequate liver function level

Child-Pugh class (A) or (B)

Bilirubin ≤ 2.4 mg/dL

Absence of ascites

BCLC intermediate stage (B)

N1 tumor nodule → diameter > 3.0 cm

Max N3 tumor nodules → diameter ≤ 3.0 cm

ECOG performance status of 0 to 2

TACE: Trans-arterial chemoembolization; HCC: Hepatocellular carcinoma; BCLC: Barcelona Clinic Liver Cancer; ECOG: European Cooperative Oncology Group.

Citation: Ranieri G, Ammendola M, Marech I, Laterza A, Abbate I, Oakley C, Vacca A, Sacco R, Gadaleta CD. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients. World J Gastroenterol 2015; 21(19): 6018-6025
URL: https://www.wjgnet.com/1007-9327/full/v21/i19/6018.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i19.6018